A fludarabine-based conditioning regimen for severe aplastic anemia

Bone Marrow Transplantation

Volumn 27, Issue 2, 2001, Pages 125-128

  Chan, K W ^a   Li, C K ^b   Worth, L L ^a   Chik, K W ^b   Jeha, S ^a   Shing, M K ^b   Yuen, P M ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Allogeneic stem cell transplantation; Alternative donors; Fludarabine; Severe aplastic anemia

Indexed keywords

ACICLOVIR; BUTADIENE DIEPOXIDE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; FLUDARABINE; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; NARCOTIC AGENT; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGRAFT; APLASTIC ANEMIA; ARTICLE; CHILD; CHIMERA; CLINICAL ARTICLE; CLINICAL TRIAL; COMPLICATION; DISEASE SEVERITY; DONOR; DRUG TOLERABILITY; ENTERITIS; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; IRRADIATION; MUCOSA INFLAMMATION; OUTCOMES RESEARCH; PRIORITY JOURNAL; REFRACTORY ANEMIA; TOXICITY;

ANEMIA, APLASTIC; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE;

EID: 0035131761     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702768     Document Type: Article

References (21)

1. Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives: An update of the Seattle experience
2. Treatment of acquired severe aplastic anemia for the EBMT working party on SAA
3. Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy
4. Treatment of acquired severe aplastic anemia: Bone marrow transplantation compared with immunosuppressive therapy - The European group for blood and marrow transplantation experience
5. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: Long-term follow-up from a single center
6. Unrelated donor marrow transplantation for severe acquired aplastic anemia using cyclophosphamide, antithymocyte globulin, and total body irradiation
7. Marrow transplantation from unrelated donors for patients with aplastic anemia who failed immunosuppressive therapy
8. Graft failure following bone marrow transplantations for severe aplastic anemia: Risk factors and treatment results
9. Bone marrow transplantation for severe aplastic anemia. Influence of conditioning regimen and graft-versus-host disease prophylaxis regimens on outcome
10. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: Harnessing graft-versus-leukemia without myeloablative therapy
11. Non-myeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases
12. Regimen-related toxicity in patients undergoing bone marrow transplantation
13. Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia
14. Unrelated donor bone marrow transplantation to treat severe aplastic anemia in children and young adults
15. Marrow transplantation from unrelated donors for patients with aplastic anemia (AA) - Optimization of a conditioning regimen
16. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia
17. Cyclophosphamide plus ATG is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors
18. Superior results following matched unrelated donor bone marrow transplants in severe aplastic anemia patients using a non-TBI containing preparative regimen
19. Transplant-lite: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment of lymphoid malignancies
20. Alternate donor transplants for aplastic anemia: Unmanipulated bone marrow following conditioning with fludarabine, cyclophosphamide and anti-thymocyte globulin
21. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis)